<p>TD Waterhouse Canada Inc. 在最近向证券交易委员会提交的 13F 表格中表示，在第四季度将其在 TransMedics Group, Inc. (NASDAQ:TMDX - 免费报告) 的持股减少了 90.8%。该机构投资者在季度内出售了 4,173 股后，持有该公司 425 股股票。TD Waterhouse Canada Inc. 在 TransMedics Group 的持股在最近的报告期末价值为 26,000 美元。</p>
<p>获取 <strong>TransMedics Group</strong> 警报：</p>
<ul>
<li>3 只远低于 52 周高点且具有强劲增长预期的股票</li>
</ul>
<p>其他对冲基金和机构投资者最近也对该公司的持股进行了调整。Vanguard Group Inc. 在第四季度将其在 TransMedics Group 的持股增加了 1.1%。Vanguard Group Inc. 目前拥有 3,635,919 股该公司的股票，价值 226,700,000 美元，此前在该期间内又增持了 40,860 股。FIL Ltd 在第四季度将其在 TransMedics Group 的持股增加了 28.0%。FIL Ltd 目前拥有 1,000,358 股该公司的股票，价值 62,372,000 美元，此前在该期间内又增持了 218,961 股。Geode Capital Management LLC 在第四季度将其在 TransMedics Group 的持股增加了 1.2%。Geode Capital Management LLC 目前拥有 772,744 股该公司的股票，价值 48,191,000 美元，此前在该期间内又增持了 8,954 股。Wasatch Advisors LP 在第四季度将其在 TransMedics Group 的持股增加了 83.3%。Wasatch Advisors LP 目前拥有 441,354 股该公司的股票，价值 27,518,000 美元，此前在该期间内又增持了 200,603 股。最后，Emerald Advisers LLC 在第四季度将其在 TransMedics Group 的持股增加了 146.3%。Emerald Advisers LLC 目前拥有 371,711 股该公司的股票，价值 23,176,000 美元，此前在该期间内又增持了 220,804 股。99.67% 的股票由机构投资者持有。</p>
<h2>分析师评级上调与下调</h2>
<p>TMDX 已成为多份研究分析师报告的主题。Needham &amp; Company LLC 在 4 月 23 日的报告中重申了对 TransMedics Group 股票的 &#34;持有&#34; 评级。Canaccord Genuity Group 在 3 月 11 日的研究报告中重申了 &#34;买入&#34; 评级，并对 TransMedics Group 股票设定了 104.00 美元的目标价。三位分析师对该股票给予了持有评级，七位给予了买入评级，一位给予了强烈买入评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 &#34;适度买入&#34;，共识目标价为 122.70 美元。</p>
<p><strong>获取我们对 TransMedics Group 的最新分析</strong></p>
<h2>TransMedics Group 股票表现</h2>
<p>NASDAQ TMDX 的股票在周二开盘价为 90.19 美元。该股票的 50 日移动平均价格为 74.67 美元，200 日移动平均价格为 77.10 美元。TransMedics Group, Inc. 的 52 周低点为 55.00 美元，52 周高点为 177.37 美元。该公司的债务与股本比率为 2.42，速动比率为 7.33，流动比率为 8.20。该股票的市值为 30.5 亿美元，市盈率为 95.95，贝塔系数为 2.14。</p>
<h2>关于 TransMedics Group</h2>
<p>(免费报告)</p>
<p>TransMedics Group, Inc. 是一家商业阶段的医疗技术公司，致力于为美国及国际上的终末期器官衰竭患者转变器官移植治疗。该公司提供器官护理系统 (OCS)，这是一种便携式器官灌注、优化和监测系统，利用其专有和定制的技术在人体外复制接收器官的近生理条件。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票，胜过 TransMedics Group</li>
<li>WallStreetBets 是什么，它们正在瞄准哪些股票？</li>
<li>2025 年最佳防御股票……到目前为止</li>
<li>如何做空纳斯达克：易于遵循的指南</li>
<li>Alphabet 在强劲的财报和回购公告后反弹</li>
<li>深入了解买卖价差</li>
<li>出售台积电会是巴菲特最大的遗憾吗？</li>
</ul>
<p><strong>想看看其他对冲基金持有的 TMDX 吗？</strong> 访问 HoldingsChannel.com 获取 TransMedics Group, Inc. (NASDAQ:TMDX - 免费报告) 的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VE1EWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VE1EWA"/></p>
<p><em>此即时新闻警报由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审查。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 TransMedics Group 吗？</h2>
<p>在你考虑 TransMedics Group 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 TransMedics Group 并不在名单上。</p>
<p>虽然 TransMedics Group 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

TMDX

<p>TD Waterhouse Canada Inc. 在第四季度通过出售 4,173 股大幅减少了对 TransMedics Group, Inc. (NASDAQ:TMDX) 的持股，持股量减少了 90.8%。该公司目前持有 425 股，价值 26,000 美元。其他机构投资者，包括先锋集团和 FIL 有限公司，也调整了他们在 TMDX 的持仓。该股票目前的市值为 30.5 亿美元，平均评级为 “适度买入”，共识目标价为 122.70 美元</p>

<p>TD Waterhouse Canada Inc. trimmed its position in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 90.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The institutional investor owned 425 shares of the company's stock after selling 4,173 shares during the quarter. TD Waterhouse Canada Inc.'s holdings in TransMedics Group were worth $26,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>TD Waterhouse Canada Inc. 在最近向证券交易委员会提交的 13F 表格中表示，在第四季度将其在 TransMedics Group, Inc. (NASDAQ:TMDX - 免费报告) 的持股减少了 90.8%。该机构投资者在季度内出售了 4,173 股后，持有该公司 425 股股票。TD Waterhouse Canada Inc. 在 TransMedics Group 的持股在最近的报告期末价值为 26,000 美元。</p>
</div><p>Get <strong>TransMedics Group</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>TransMedics Group</strong> 警报：</p>
</div><ul>
<li>3 Stocks Well Below 52-Week Highs With Strong Growth Projections</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只远低于 52 周高点且具有强劲增长预期的股票</li>
</ul>
</div><p>Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. raised its holdings in shares of TransMedics Group by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 3,635,919 shares of the company's stock worth $226,700,000 after acquiring an additional 40,860 shares during the period. FIL Ltd raised its holdings in shares of TransMedics Group by 28.0% during the fourth quarter. FIL Ltd now owns 1,000,358 shares of the company's stock worth $62,372,000 after acquiring an additional 218,961 shares during the period. Geode Capital Management LLC raised its holdings in shares of TransMedics Group by 1.2% during the fourth quarter. Geode Capital Management LLC now owns 772,744 shares of the company's stock worth $48,191,000 after acquiring an additional 8,954 shares during the period. Wasatch Advisors LP raised its holdings in shares of TransMedics Group by 83.3% during the fourth quarter. Wasatch Advisors LP now owns 441,354 shares of the company's stock worth $27,518,000 after acquiring an additional 200,603 shares during the period. Finally, Emerald Advisers LLC raised its holdings in shares of TransMedics Group by 146.3% during the fourth quarter. Emerald Advisers LLC now owns 371,711 shares of the company's stock worth $23,176,000 after acquiring an additional 220,804 shares during the period. 99.67% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>其他对冲基金和机构投资者最近也对该公司的持股进行了调整。Vanguard Group Inc. 在第四季度将其在 TransMedics Group 的持股增加了 1.1%。Vanguard Group Inc. 目前拥有 3,635,919 股该公司的股票，价值 226,700,000 美元，此前在该期间内又增持了 40,860 股。FIL Ltd 在第四季度将其在 TransMedics Group 的持股增加了 28.0%。FIL Ltd 目前拥有 1,000,358 股该公司的股票，价值 62,372,000 美元，此前在该期间内又增持了 218,961 股。Geode Capital Management LLC 在第四季度将其在 TransMedics Group 的持股增加了 1.2%。Geode Capital Management LLC 目前拥有 772,744 股该公司的股票，价值 48,191,000 美元，此前在该期间内又增持了 8,954 股。Wasatch Advisors LP 在第四季度将其在 TransMedics Group 的持股增加了 83.3%。Wasatch Advisors LP 目前拥有 441,354 股该公司的股票，价值 27,518,000 美元，此前在该期间内又增持了 200,603 股。最后，Emerald Advisers LLC 在第四季度将其在 TransMedics Group 的持股增加了 146.3%。Emerald Advisers LLC 目前拥有 371,711 股该公司的股票，价值 23,176,000 美元，此前在该期间内又增持了 220,804 股。99.67% 的股票由机构投资者持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调与下调</h2>
</div><p>TMDX has been the topic of a number of research analyst reports. Needham &amp; Company LLC restated a &#34;hold&#34; rating on shares of TransMedics Group in a report on Wednesday, April 23rd. Canaccord Genuity Group reiterated a &#34;buy&#34; rating and issued a $104.00 price target on shares of TransMedics Group in a research note on Tuesday, March 11th. Three analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $122.70.</p>
<div class="lb-trans"><p>TMDX 已成为多份研究分析师报告的主题。Needham &amp; Company LLC 在 4 月 23 日的报告中重申了对 TransMedics Group 股票的 &#34;持有&#34; 评级。Canaccord Genuity Group 在 3 月 11 日的研究报告中重申了 &#34;买入&#34; 评级，并对 TransMedics Group 股票设定了 104.00 美元的目标价。三位分析师对该股票给予了持有评级，七位给予了买入评级，一位给予了强烈买入评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 &#34;适度买入&#34;，共识目标价为 122.70 美元。</p>
</div><p><strong>Get Our Latest Analysis on TransMedics Group</strong></p>
<div class="lb-trans"><p><strong>获取我们对 TransMedics Group 的最新分析</strong></p>
</div><h2>TransMedics Group Stock Performance</h2>
<div class="lb-trans"><h2>TransMedics Group 股票表现</h2>
</div><p>Shares of NASDAQ TMDX opened at $90.19 on Tuesday. The stock has a 50 day moving average price of $74.67 and a 200 day moving average price of $77.10. TransMedics Group, Inc. has a 52 week low of $55.00 and a 52 week high of $177.37. The company has a debt-to-equity ratio of 2.42, a quick ratio of 7.33 and a current ratio of 8.20. The stock has a market capitalization of $3.05 billion, a PE ratio of 95.95 and a beta of 2.14.</p>
<div class="lb-trans"><p>NASDAQ TMDX 的股票在周二开盘价为 90.19 美元。该股票的 50 日移动平均价格为 74.67 美元，200 日移动平均价格为 77.10 美元。TransMedics Group, Inc. 的 52 周低点为 55.00 美元，52 周高点为 177.37 美元。该公司的债务与股本比率为 2.42，速动比率为 7.33，流动比率为 8.20。该股票的市值为 30.5 亿美元，市盈率为 95.95，贝塔系数为 2.14。</p>
</div><h2>About TransMedics Group</h2>
<div class="lb-trans"><h2>关于 TransMedics Group</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>TransMedics Group, Inc, a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.</p>
<div class="lb-trans"><p>TransMedics Group, Inc. 是一家商业阶段的医疗技术公司，致力于为美国及国际上的终末期器官衰竭患者转变器官移植治疗。该公司提供器官护理系统 (OCS)，这是一种便携式器官灌注、优化和监测系统，利用其专有和定制的技术在人体外复制接收器官的近生理条件。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than TransMedics Group</li>
<li>What Is WallStreetBets and What Stocks Are They Targeting?</li>
<li>Best Defense Stocks in 2025... So Far</li>
<li>How to Short Nasdaq: An Easy-to-Follow Guide</li>
<li>Alphabet Rebounds After Strong Earnings and Buyback Announcement</li>
<li>A Deeper Look at Bid-Ask Spreads</li>
<li>Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 TransMedics Group</li>
<li>WallStreetBets 是什么，它们正在瞄准哪些股票？</li>
<li>2025 年最佳防御股票……到目前为止</li>
<li>如何做空纳斯达克：易于遵循的指南</li>
<li>Alphabet 在强劲的财报和回购公告后反弹</li>
<li>深入了解买卖价差</li>
<li>出售台积电会是巴菲特最大的遗憾吗？</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding TMDX?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TransMedics Group, Inc. (NASDAQ:TMDX - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对冲基金持有的 TMDX 吗？</strong> 访问 HoldingsChannel.com 获取 TransMedics Group, Inc. (NASDAQ:TMDX - 免费报告) 的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VE1EWA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=TMDX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻警报由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审查。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in TransMedics Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 TransMedics Group 吗？</h2>
</div><p>Before you consider TransMedics Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 TransMedics Group 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TransMedics Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 TransMedics Group 并不在名单上。</p>
</div><p>While TransMedics Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 TransMedics Group 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

TD Waterhouse Canada Inc. 出售了 4,173 股 TransMedics Group, Inc.（NASDAQ 代码：TMDX）的股票